Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sunitibenz 25 Capsule

Prescription Icon
Prescription Required

Marketer

Admac Pharma Ltd

Salt Composition

Sunitinib (25mg)

Overview Sunitibenz 25 Capsule

Sutent 25mg capsules treat kidney and gastrointestinal stromal tumors. Its mechanism involves inhibiting enzymes crucial for cancer cell proliferation, thus reducing tumor size and growth rate. This medication can be taken with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be necessary. This medication can lower blood sugar levels, potentially causing hypoglycemia and fainting; diabetics should monitor glucose levels frequently and discuss potential anti-diabetic dosage adjustments with their doctor. Inform your doctor of pre-existing heart, liver, kidney disease, or bleeding disorders before starting treatment. Interactions with other medications are possible; disclose all current medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.

Uses of Sunitibenz 25 Capsule

Kidney and gastrointestinal stromal tumor therapies

Major Benefits of Sunitibenz 25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitibenz 25 Capsules. These capsules can be ingested with or without food; however, consistent timing is recommended.

Common Side effects of Sunitibenz 25 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sunitibenz 25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitibenz 25 Capsule. This medication can be administered with or without food, although consistent timing is recommended.

How Sunitibenz 25 Capsule works:

Sunitibenz 25 Capsules are an anticancer agent. Their mechanism of action involves targeted inhibition of tyrosine kinase, a cell surface protein crucial for cancer cell multiplication. Concurrently, they suppress angiogenesis, the formation of new blood vessels supplying the tumor, thus hindering the spread of cancerous cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Sunitibenz 25 Capsule may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sunitibenz 25 Capsule during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sunitibenz 25 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Sunitibenz 25 Capsule, which can induce dizziness. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Sunitibenz 25 Capsule poses no safety concerns for patients with kidney impairment; no dosage modification is necessary.

LiverLiverSAFE IF PRESCRIBED

Liver impairment does not necessitate a dosage change for Sunitibenz 25 Capsule, which is considered safe for such patients.

What if you forget to take Sunitibenz 25 Capsule :

Omit any missed Sunitibenz 25 Capsule dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sunitibenz 25 Capsule

LabelValue
Type of Compound Compounds derived from indole and pyrrole.
Addictive None.
Medication Category Cancer-fighting drugs

FAQs on Sunitibenz 25 Capsule

Follow your physician's instructions precisely when using Sunitibenz 25 Capsule. Prescribing should be limited to oncologists experienced in cancer chemotherapy. Administer one capsule daily, with or without food. Avoid grapefruit and grapefruit juice throughout your Sunitibenz 25 Capsule treatment course to minimize the risk of adverse reactions.
Skin lightening and hair loss are potential side effects of Sunitibenz 25 Capsule therapy. Patients may also develop dry, thickened, or cracked skin, blisters, or rashes on their hands and feet. These effects typically resolve upon discontinuation of the medication. However, Sunitibenz 25 Capsule can cause serious, potentially life-threatening skin reactions, including severe rashes or rapidly spreading skin sores. Report any signs of infection near a skin wound, such as fever, pain, redness, swelling, or pus/blood discharge, to your physician immediately.
Taking Sunitibenz 25 Capsules carries a risk of severe liver complications, potentially fatal. Report any itching, jaundice (yellowing of eyes or skin), dark urine, or right upper abdominal pain or discomfort to your physician immediately. Liver function blood tests will be conducted before and throughout your Sunitibenz 25 Capsule treatment. If liver problems arise, your doctor might suspend or discontinue the medication.
Sunitibenz 25 Capsule currently lacks generic alternatives. Its mechanism involves inhibiting a protein kinase enzyme, a surface protein on cancer cells that fuels their growth and metastasis. This targeted enzyme inhibition prevents cancerous proliferation. Other medications that similarly target protein kinases include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
No research validates combining Sunitibenz 25 Capsule with other chemotherapeutic agents. Its application in gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, is specifically for cases where imatinib, an alternative anticancer drug, proves ineffective or is unsuitable for the patient.
Sunitibenz 25 Capsule can lower blood glucose. Diabetic patients should monitor their blood sugar closely as it may drop dangerously low, potentially causing unconsciousness. Adjustments to antidiabetic medication dosage may be necessary depending on blood glucose readings.
Sunitibenz 25 Capsule often elevates blood pressure. Consequently, consistent blood pressure monitoring is crucial. Report severe headache, dizziness, lightheadedness, or visual disturbances to your physician immediately. They may then prescribe antihypertensive medication or temporarily suspend your Sunitibenz 25 Capsule treatment until your blood pressure normalizes.
Sunitibenz 25 Capsule
3,172
MRP 3,864
17% off